胰腺癌与乙型肝炎感染的研究进展
Advances in study on association between pancreatic carcinoma and hepatitis B virus
孙文韬, 邓侠兴 . 胰腺癌与乙型肝炎感染的研究进展[J]. 外科理论与实践, 2020 , 25(02) : 171 -173 . DOI: 10.16139/j.1007-9610.2020.02.018
| [1] | Hassan MM, Li D, El-Deeb AS, et al. Association between hepatitis B virus and pancreatic cancer[J]. J Clin Oncol, 2008, 26(28):4557-4562. |
| [2] | Wang DS, Chen DL, Ren C, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer[J]. Int J Cancer, 2012, 131(2):461-468. |
| [3] | Ben Q, Li Z, Liu C, et al. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China[J]. Pancreas, 2012, 41(3):435-440. |
| [4] | Desai R, Patel U, Sharma S, et al. Association between hepatitis B infection and pancreatic cancer: a population-based analysis in the United States[J]. Pancreas, 2018, 47(7):849-855. |
| [5] | Zhu F, Li HR, Du GN, et al. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China[J]. Asian Pac J Cancer Prev, 2011, 12(6):1405-1408. |
| [6] | Chang MC, Chen CH, Liang JD, et al. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma[J]. World J Gastroenterol, 2014, 20(17):5060-5065. |
| [7] | Iloeje UH, Yang HI, Jen CL, et al. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study[J]. Liver Int, 2010, 30(3):423-429. |
| [8] | Tang J, Sharma R, Lamerato L, et al. Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma[J]. J Clin Gastroenterol, 2014, 48(8):729-733. |
| [9] | Krull AS, Inoue M, Sawada N, et al. Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC Study CohortⅡ)[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(3):555-557. |
| [10] | Huang J, Magnusson M, Törner A, et al. Risk of pancrea- tic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden[J]. Br J Cancer, 2013, 109(11):2917-2923. |
| [11] | Andersen ES, Omland LH, Jepsen P, et al. Risk of all-type cancer, hepatocellular carcinoma, non-Hodgkin lymphoma and pancreatic cancer in patients infected with hepatitis B virus[J]. J Viral Hepat, 2015, 22(10):828-834. |
| [12] | Xing S, Li ZW, Tian YF, et al. Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(6):575-583. |
| [13] | Luo G, Hao NB, Hu CJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis[J]. Cancer Causes Control, 2013, 24(3):529-537. |
| [14] | Fiorino S, Chili E, Bacchi-Reggiani L, et al. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis[J]. Pancreatology, 2013, 13(2):147-160. |
| [15] | Wang Y, Yang S, Song F, et al. Hepatitis B virus status and the risk of pancreatic cancer: a meta-analysis[J]. Eur J Cancer Prev, 2013, 22(4):328-334. |
| [16] | Xu JH, Fu JJ, Wang XL, et al. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies[J]. World J Gastroenterol, 2013, 19(26):4234-4241. |
| [17] | Dejean A, Lugassy C, Zafrani S, et al. Detection of he- patitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus[J]. J Gen Virol, 1984, 65(Pt 3):651-655. |
| [18] | Hoefs JC, Renner IG, Askhcavai M, et al. Hepatitis B surface antigen in pancreatic and biliary secretions[J]. Gastroenterology, 1980, 79(2):191-194. |
| [19] | Jin Y, Gao H, Chen H, et al. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues[J]. Cancer Lett, 2013, 335(2):447-454. |
| [20] | Hohenberger P. The pancreas as target organ for hepatitis B virus--immunohistological detection of HBsAg in pancreatic carcinoma and chronic pancreatitis[J]. Leber Magen Darm, 1985, 15(2):58-63. |
| [21] | Fiorino S, Visani M, Acquaviva G, et al. Search for HBV and HCV genome in cancer cells of pancreatic tumors[J]. Pancreas, 2016, 45(1):e12-e14. |
| [22] | Pang Y, Kartsonaki C, Guo Y, et al. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies[J]. Int J Cancer, 2017, 140(8):1781-1788. |
| [23] | Kirkegård J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2017, 112(9):1366-1372. |
| [24] | Brooks-Worrell B, Palmer JP. Immunology in the clinic review series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation[J]. Clin Exp Immunol, 2012, 167(1):40-46. |
| [25] | Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma[J]. J Hepatol, 2016, 64(1 Suppl):S84-S101. |
| [26] | Chen Y, Bai X, Zhang Q, et al. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway[J]. Cancer Lett, 2016, 380(1):98-105. |
| [27] | Fiorino S, Bacchi-Reggiani L, Pontoriero L, et al. Tensegrity model hypothesis: may this paradigm be useful to explain hepatic and pancreatic carcinogenesis in patients with persistent hepatitis B or hepatitis C virus infection[J]. JOP, 2014, 15(2):151-164. |
| [28] | Zou J, Chen J, Xie X, et al. Hepatitis B virus infection is a prognostic biomarker for better survival in operable esophageal cancer: analysis of 2004 patients from an endemic area in China[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(6):1028-1035. |
| [29] | Tanase AM, Dumitrascu T, Dima S, et al. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):162-172. |
| [30] | Wei XL, Luo HY, Li CF, et al. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers[J]. Int J Cancer, 2017, 141(1):152-159. |
| [31] | Wei XL, Qiu MZ, Chen WW, et al. The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer[J]. J Transl Med, 2013, 11:249. |
| [32] | Dumitrascu T, Pineau P, Dima S, et al. Impact of hepatitis B virus on clinicopathological features and outcomes after resection for pancreatic adenocarcinoma[J]. Anticancer Res, 2015, 35(9):5123-5128. |
| [33] | Zhou X, Wang X, Duan J, et al. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas[J]. Pathol Res Pract, 2019, 215(2):343-346. |
| [34] | Oksüzoğlu B, Kiliçkap S, Yalcin S. Reactivation of he- patitis B virus infection in pancreatic cancer: a case report[J]. Jpn J Clin Oncol, 2002, 32(12):543-545. |
| [35] | 孙德聪, 陈丽, 吴志勇, 等. 化疗相关乙肝病毒再激活的诊治现状[J]. 中国临床药理学与治疗学, 2014, 19(5):584-590. |
/
| 〈 |
|
〉 |
